BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8629551)

  • 1. Saquinavir for treatment of patients with HIV.
    Am Fam Physician; 1996 Feb; 53(2):782, 785. PubMed ID: 8629551
    [No Abstract]   [Full Text] [Related]  

  • 2. New protease inhibitor studies.
    Treat Rev; 1995 Nov; (no 20):3. PubMed ID: 11363020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance slow to emerge in combination therapy.
    AIDS Patient Care; 1995 Dec; 9(6):303-4. PubMed ID: 11361441
    [No Abstract]   [Full Text] [Related]  

  • 4. Trial volunteers sought.
    Meyer C
    Am J Nurs; 1993 May; 93(5):12. PubMed ID: 8488890
    [No Abstract]   [Full Text] [Related]  

  • 5. Protease inhibitor trials moving to next phase.
    AIDS Alert; 1995 Aug; 10(8):100-1. PubMed ID: 11362675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The safety and efficacy of saquinavir in the therapy of HIV infection].
    Dtsch Med Wochenschr; 1995 Dec; 120(49):1721. PubMed ID: 7497905
    [No Abstract]   [Full Text] [Related]  

  • 7. Lottery opens 2,000 slots for protease trial.
    AIDS Alert; 1995 Nov; 10(11):144. PubMed ID: 11362929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [For the first time a combination of 2 protease inhibitors investigated].
    Schenk M
    Dtsch Med Wochenschr; 1996 Aug; 121(34-35):A36. PubMed ID: 8829900
    [No Abstract]   [Full Text] [Related]  

  • 9. Saquinavir prolongs survival and slows disease progression.
    BETA; 1996 Jun; ():6. PubMed ID: 11363649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saquinavir (Roche protease inhibitor) at higher doses.
    AIDS Treat News; 1995 Sep; (no 231):5. PubMed ID: 11362870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No tease this time--pros and cons of a long-awaited anti-HIV drug.
    Chang HE
    Posit Aware; 1996; 7(1):18-20. PubMed ID: 11363118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on HIV protease inhibitors.
    Vella S
    AIDS Clin Care; 1995 Oct; 7(10):79-82, 88. PubMed ID: 11362832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ritonavir/saquinavir trial announced.
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):59. PubMed ID: 11363522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invirase program expands.
    AIDS Patient Care; 1995 Dec; 9(6):305. PubMed ID: 11361444
    [No Abstract]   [Full Text] [Related]  

  • 15. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saquinavir (Invirase).
    Treat Rev; 1996 Apr; (no 21):5. PubMed ID: 11363396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European hurdles for saquinavir.
    J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):44. PubMed ID: 11363099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stanford study of saquinavir reveals low toxicities.
    AIDS Patient Care; 1995 Dec; 9(6):304-5. PubMed ID: 11361442
    [No Abstract]   [Full Text] [Related]  

  • 19. Saquinavir (Invirase): first protease inhibitor approved--reimbursement, information hotline numbers.
    James JS
    AIDS Treat News; 1995 Dec; (no 237):1-2. PubMed ID: 11363073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roche submits NDA for Invirase.
    J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):37-8. PubMed ID: 11362796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.